150 related articles for article (PubMed ID: 23675279)
1. Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia.
Jiménez P; Alvarez JC; Garrido P; Lorente JA; Palacios J; Ruiz-Cabello F
Int J Biomed Sci; 2012 Dec; 8(4):244-8. PubMed ID: 23675279
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
[TBL] [Abstract][Full Text] [Related]
4. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.
Cooley LD; Sears DA; Udden MM; Harrison WR; Baker KR
Am J Hematol; 2000 Jan; 63(1):46-53. PubMed ID: 10602169
[TBL] [Abstract][Full Text] [Related]
5. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
[TBL] [Abstract][Full Text] [Related]
6. Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor.
Bobadilla-Morales L; Pimentel-Gutiérrez HJ; Gallegos-Castorena S; Paniagua-Padilla JA; Ortega-de-la-Torre C; Sánchez-Zubieta F; Silva-Cruz R; Corona-Rivera JR; Zepeda-Moreno A; González-Ramella O; Corona-Rivera A
Mol Cytogenet; 2015; 8():5. PubMed ID: 25674158
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
8. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
10. Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT?
Palka G; Lawler M; Morizio E; Gardiner N; Stuppia L; De Arce MA; Di Bartolomeo PD; Capodiferro F; Sabatino G; Gatta V; Calabrese G; Cann SR
Hematology; 1998; 3(3):193-203. PubMed ID: 27416528
[TBL] [Abstract][Full Text] [Related]
11. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
12. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
[TBL] [Abstract][Full Text] [Related]
13. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.
Lowsky R; Fyles G; Minden M; Lipton J; Meharchand J; Tejpar I; Zipursky A; Messner H
Br J Haematol; 1996 Apr; 93(1):163-5. PubMed ID: 8611454
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell-surface antigens in acute promyelocytic leukaemia.
Paietta E
Best Pract Res Clin Haematol; 2003 Sep; 16(3):369-85. PubMed ID: 12935957
[TBL] [Abstract][Full Text] [Related]
15. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life.
Beelen DW; Quabeck K; Mahmoud HK; Schaefer UW; Becher R; Schmidt CG; Bamberg M; Quast U; Grosse-Wilde H; Haralambie E
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1665-71. PubMed ID: 3322846
[TBL] [Abstract][Full Text] [Related]
17. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.
Au WY; Lie AK; Lee CK; Liang R; Kwong YL
Bone Marrow Transplant; 1999 Jun; 23(11):1201-3. PubMed ID: 10382962
[TBL] [Abstract][Full Text] [Related]
18. Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT.
Classen CF; Debatin KM; Friedrich W; Schulz AS
Bone Marrow Transplant; 2003 Oct; 32(8):843-6. PubMed ID: 14520432
[TBL] [Abstract][Full Text] [Related]
19. Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Kharfan-Dabaja MA; Labopin M; Brissot E; Kroger N; Finke J; Ciceri F; Deconinck E; Blaise D; Chevallier P; Gramatzki M; Ganser A; Stelljes M; Edinger M; Savani B; Ruggeri A; Sanz J; Nagler A; Mohty M
Br J Haematol; 2021 May; 193(3):592-601. PubMed ID: 33838047
[TBL] [Abstract][Full Text] [Related]
20. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
Ringdén O; Labopin M; Gluckman E; Hows JM; Bradley BA; Kolb HJ; Fouillard L; Jacobsen N; Vernant JP; Witz F; Harousseau JL; Gorin NC
Bone Marrow Transplant; 1997 May; 19(10):963-8. PubMed ID: 9169639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
